Nuvation bio inc NUVB.US Value Analysis
NUVB Value Score
3
24
15
- AI analysis rates NUVB with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, NUVB has maintained a consecutive value rating of 2.0, slightly higher than the rating of 1.1 over the past 3 years. However, growth opportunities for enterprise value remain relatively low.
- Compared to all stocks in the Health Care sector, NUVB has a medium value rating.
NUVB Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/08 (Weekly Update)
NUVB Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
NUVB Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -0.15 | - | 7.1% | 5.71M | - | 585.3% | -5,668.5% |
Update to 2025/5/9 (Quarterly Update)
NUVB Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
NUVB Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
The Backtest Result of NUVB from 2020/09 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from September, 2020 to May, 2025. (Total Trades: 0)
| NUVB | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 54% |
| Avg Return | - | 63.5% | 72.8% |
| Avg Profit | - | 198.7% | 166% |
| Avg Loss | - | -44.7% | -34.6% |
| Avg Risk-Reward Ratio | - | 444.3% | 479.7% |
Update to 2025/5/9 (Daily Update)